Investments
59Portfolio Exits
4
Want to inform investors similar to Baylor Angel Network about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Baylor Angel Network News
Aug 1, 2023
VenoStent, Inc. , a Houston, TX-based clinical-stage, venture-backed, therapeutic medical device company developing bioabsorbable wraps to improve outcomes for hemodialysis patients, completed a $16M Series A financing. The round was led by Good Growth Capital and IAG Capital Partners, with participation from TMC Venture Fund, SNR, Baylor Angel Network / Affinity Fund, Creative Ventures, Cowtown Angels, Alumni Ventures, and other angel investors. The company intends to use the funds to expand their US Pivotal Trial and their manufacturing capabilities, aiming towards FDA Approval of their novel therapeutic medical device. Led by CEO Tim Boire, Ph.D., VenoStent is a therapeutic medical device company developing a bioabsorbable wrap, SelfWrap , to transform outcomes in vascular surgery, starting with hemodialysis access. The device is intended to improve the usability and durability of arteriovenous fistulas (AVFs), the artery-vein connections that are surgically created in the arms of chronic kidney disease patients to enable life-saving dialysis treatments. The company, which has received funding in the past from KidneyX, National Science Foundation (NSF), National Institute of Health (NIH), Y Combinator, Health Wildcatters, and Texas Halo Fund, also has announced that they have been granted Investigational Device Exemption ( IDE ) from the FDA for their US clinical trial, SAVE-FistulaS. FinSMEs 01/08/2023
Baylor Angel Network Investments
59 Investments
Baylor Angel Network has made 59 investments. Their latest investment was in VenoStent as part of their Series A on July 7, 2023.
Baylor Angel Network Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
7/19/2023 | Series A | VenoStent | $16.06M | Yes | Alumni Ventures, Baylor Angel Network, Cowtown Angels, Creative Ventures, Good Growth Capital, IAG Capital Partners, SNR Ventures, Texas Medical Center Venture Fund, and Undisclosed Angel Investors | 2 |
5/15/2017 | Series C | SonarMed | $3M | No | 2 | |
11/2/2016 | Series F - II | Phunware | $22M | No | 13 | |
1/27/2016 | Bridge | |||||
1/7/2015 | Series B |
Date | 7/19/2023 | 5/15/2017 | 11/2/2016 | 1/27/2016 | 1/7/2015 |
|---|---|---|---|---|---|
Round | Series A | Series C | Series F - II | Bridge | Series B |
Company | VenoStent | SonarMed | Phunware | ||
Amount | $16.06M | $3M | $22M | ||
New? | Yes | No | No | ||
Co-Investors | Alumni Ventures, Baylor Angel Network, Cowtown Angels, Creative Ventures, Good Growth Capital, IAG Capital Partners, SNR Ventures, Texas Medical Center Venture Fund, and Undisclosed Angel Investors | ||||
Sources | 2 | 2 | 13 |
Baylor Angel Network Portfolio Exits
4 Portfolio Exits
Baylor Angel Network has 4 portfolio exits. Their latest portfolio exit was Modern Message on January 22, 2020.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
1/22/2020 | Acquired | 1 | |||
Date | 1/22/2020 | |||
|---|---|---|---|---|
Exit | Acquired | |||
Companies | ||||
Valuation | ||||
Acquirer | ||||
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
